These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2729322)

  • 1. Macroprolactinemia as the cause of elevated serum prolactin in men.
    Wortsman J; Carlson HE; Malarkey WB
    Am J Med; 1989 Jun; 86(6 Pt 1):704-6. PubMed ID: 2729322
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperprolactinemia due to big big prolactin is differently detected by commercially available immunoassays.
    Cavaco B; Prazeres S; Santos MA; Sobrinho LG; Leite V
    J Endocrinol Invest; 1999 Mar; 22(3):203-8. PubMed ID: 10219888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Macroprolactinemia--a more common cause of hyperprolactinemia than generally believed].
    Sane T; Hekim C; Alfthan H; Stenman UH; Välimäki M
    Duodecim; 2002; 118(16):1671-5. PubMed ID: 12271945
    [No Abstract]   [Full Text] [Related]  

  • 4. [Macroprolactinemia, a variety of hyperprolactinemia. Apropos of 5 cases].
    Recchi V; Hieronimus S; Creisson G; Freychet P; Morange I; Canivet B
    Rev Med Interne; 1997; 18(4):320-3. PubMed ID: 9161560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical and laboratory aspects of the phenomenon of macroprolactinemia].
    Mel'nichenko GA; Goncharov NP; Dzeranova LK; Barmina II
    Vestn Ross Akad Med Nauk; 2007; (3):52-4. PubMed ID: 17500216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of macroprolactinemia in hyperprolactinemia.
    Kasum M; Pavičić-Baldani D; Stanić P; Orešković S; Sarić JM; Blajić J; Juras J
    Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():28-32. PubMed ID: 25461348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macroprolactinemia: the consequences of a laboratory pitfall.
    Toldy E; Löcsei Z; Szabolcs I; Góth MI; Kneffel P; Szöke D; Kovács GL
    Endocrine; 2003 Dec; 22(3):267-73. PubMed ID: 14709800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Macroprolactinemia identification in patients with hyperprolactinemia].
    Sandoval C; González B; Cheng S; Esquenazi Y; Mercado M
    Ginecol Obstet Mex; 2007 Aug; 75(8):459-64. PubMed ID: 18293675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macroprolactinemia in childhood and adolescence: a cause of asymptomatic hyperprolactinemia.
    Fideleff HL; Ruibal G; Boquete H; Pujol A; Sequera A; Sobrado P
    Horm Res; 2000; 53(1):16-9. PubMed ID: 10965215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of measuring macroprolactin in the differential diagnosis of hyperprolactinemic patients.
    Lu CC; Hsieh CJ
    Kaohsiung J Med Sci; 2012 Feb; 28(2):94-9. PubMed ID: 22313536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decision cut-off of the polyethylene glycol precipitation technique in screening for macroprolactinemia on Immulite 2000.
    Rivero A; Alonso E; Grijalba A
    Clin Chem Lab Med; 2004 May; 42(5):566-8. PubMed ID: 15202797
    [No Abstract]   [Full Text] [Related]  

  • 12. Asymptomatic hyperprolactinemia resulting from macroprolactinemia.
    Corenblum B
    Fertil Steril; 1990 Jan; 53(1):165-7. PubMed ID: 2295337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Macroprolactinemia in a child].
    Weill J; Petit S; Stuckens C; Descamps Y; Racadot A; Boersma A; Ponte C
    Arch Fr Pediatr; 1990 Oct; 47(8):595-6. PubMed ID: 2078111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory and clinical significance of macroprolactinemia in women with hyperprolactinemia.
    Kasum M; Orešković S; Čehić E; Šunj M; Lila A; Ejubović E
    Taiwan J Obstet Gynecol; 2017 Dec; 56(6):719-724. PubMed ID: 29241908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characterization of patients with macroprolactinemia and monomeric hyperprolactinemia.
    Can M; Guven B; Atmaca H; Acıkgoz S; Mungan G
    Kaohsiung J Med Sci; 2011 May; 27(5):173-6. PubMed ID: 21527183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of macroprolactinemia in the differential diagnosis of hyperprolactinemic patients.
    Bağdatoğlu C; Bağdatoğlu OT; Muslu N; Köseoğlu A; Dağtekin A; Polat G; Dolgun H; Karataş MA
    Turk Neurosurg; 2008 Jul; 18(3):223-7. PubMed ID: 18814107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiometabolic Risk Factors in Men with Elevated Macroprolactin Content: A Pilot Study.
    Krysiak R; Szkróbka W; Okopień B
    Exp Clin Endocrinol Diabetes; 2021 Jan; 129(1):7-13. PubMed ID: 31185509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and laboratory features greatly overlap in patients with macroprolactinemia or monomeric hyperprolactinemia.
    Vilar L; Naves LA; Freitas MC; Lima M; Canadas V; Albuquerque JL; Lyra R; Azevedo MF; Casulari LA
    Minerva Endocrinol; 2007 Jun; 32(2):79-86. PubMed ID: 17557033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of macroprolactinemia with the polyethylene glycol precipitation test in systemic lupus erythematosus patients with hyperprolactinemia.
    Leaños-Miranda A; Pascoe-Lira D; Chávez-Rueda KA; Blanco-Favela F
    Lupus; 2001; 10(5):340-5. PubMed ID: 11403264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The macroprolactinemia problem and its solution.
    Fahie-Wilson M
    South Med J; 2006 Nov; 99(11):1206. PubMed ID: 17195412
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.